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Ozone treatment of recurrent 
aphthous stomatitis: a double 
blinded study
Mahmoud K. AL-Omiri1,2, Mohannad Alhijawi3, Bader K. AlZarea4, Ra’ed S. Abul Hassan5 & 
Edward Lynch6
This study aimed to evaluate the use of ozone to treat recurrent aphthous stomatitis (RAS). Consecutive 
sixty-nine participants with RAS were recruited into this non-randomized double blind, controlled 
cohort observational study (test group). A control group of 69 RAS patients who matched test 
group with age and gender was recruited. RAS lesions in test group were exposed to ozone in air for 
60 seconds while controls received only air. Ulcer size and pain were recorded for each participant at 
baseline and daily for 15 days. Ulcer duration was determined by recording the time taken for ulcers 
to disappear. The main outcome measures were pain due to the ulcer, ulcer size and ulcer duration. 
138 RAS participants (69 participants and 69 controls) were analyzed. Ulcer size was reduced starting 
from the second day in test group and from the fourth day in controls (p ≤ 0.004). Pain levels were 
reduced starting from the first day in the test group and from the third day in controls (p ≤ 0.001). 
Ulcer duration, ulcer size after day 2 and pain levels were more reduced in the test group. In conclusion, 
application of ozone on RAS lesions for 60 seconds reduced pain levels and enhanced ulcers’ healing by 
reducing ulcers’ size and duration.
Ozone (O3) therapy has gained a lot of attention in medicine and dentistry because it is a powerful oxidant, has 
strong antimicrobial activity (against bacteria, viruses, yeasts and protozoa), can stimulate blood circulation and 
the immune response, and has analgesic effects1,2. However, respiratory tract mucosal cell lining is sensitive to 
oxidation; therefore, ozone is an irritant to respiratory system and can induce and promote allergy and asthma 
if inhaled directly in high doses. This underlines the importance of using adequate delivery systems to prevent 
ozone leakage and avoid its hazards to the respiratory system1–5.
Ozone has been used to treat about 250 different pathologies1–5. Dental applications of ozone included pre-
vention and treatment of dental caries6–12, tooth remineralization3–12, infection control1–6,13, disinfection of perio-
dontal pockets14, tooth bleaching15, pain control1–5,14, management of exposed roots and tooth sensitivity3–5, TMJ 
treatment3–5, endodontic treatment3–5, biofilm purging1–5, acceleration of healing3–5, tissue regeneration2–12 and 
control of halitosis3–5.
Recurrent aphthous stomatitis (RAS) is a well known disorder that affects the oral mucosa and is distin-
guished by recurrent, single or multiple, painful, round or oval ulcers with erythematous borders16,17. It negatively 
impacts quality of life18,19. Many treatment paradigms have been used for management of oral ulcers including 
mouthrinses (such as chlorhexidine), topical corticosteroids, topical tetracycline, immunoregulators (such as 
levamisole, azathioprine and colchicine), TNF inhibitors, systemic zinc sulphate, monoamine-oxidase inhibitors, 
sodium cromoglycate, deglycirrhizinated liquorice, sucralphate etretinate, low-energy laser, herbs and others. 
Unfortunately, no specific cure for RAS is available. On the other hand, available treatments might reduce RAS 
symptoms but cannot totally cure RAS or prevent ulcer recurrences16,17.
Ozone has been used for the treatment of ulcers affecting other parts of the gastrointestinal tract20–22, blood 
vessels23 and skin24,25; however, none have studied the role of ozone in treatment of recurrent aphthous ulcers in 
the oral cavity.
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This motivated the conduction of this study in order to assess the role of ozone in management of recurrent 
aphthous ulcers.
The aim of this study was to assess the therapeutic effects of 60 seconds of ozone application on ulcer size, ulcer 
duration and pain caused by recurrent aphthous ulcers.
The null hypothesis for this study was that ozone application for 60 seconds has no role in treatment of RAS 
lesions and has no effects on ulcer size, ulcer duration or pain caused by RAS lesions.
Materials and Methods
Sixty nine consecutive patients (30 men and 39 women) aged between 18 and 40 years old (mean age  ±  SD: 
27.2  ± 7.5 years) were recruited into this parallel, controlled, double blinded study. The study was conducted 
during the period from 1st of February until 30th November 2015. The participants were diagnosed with RAS and 
were visiting dental clinics at the University of Jordan, Amman, Jordan.
This study was carried out following ethical principles, including the World Medical Association Declaration 
of Helsinki. The study was ethically approved by the Deanship of Research, University of Jordan (Reference num-
ber 15-2015). All participants were provided with a full explanation of the study, and participants’ informed 
consent was obtained before participation in the study.
In order to be included in the study, participants’ age ranged from 18 to 40 years old in order to avoid the 
potential effects of age on healing of lesions. Also, they had no diagnosed medical disease (including previous 
mental or psychological disorders, auto-inflammatory disorders, hormonal conditions, haematinic deficiencies, 
Behcet disease, diabetes, cardiovascular, hypertension, gastrointestinal, skin, liver or renal disease)16–19. In addi-
tion, participants had intraoral labial ulcers, received no treatment for the ulcers before being included in the 
study and had no active periodontitis. Participants had to present for the purpose of this study on the first day of 
ulcer appearance.
Participants with removable prosthetic rehabilitations or orthodontic appliances were excluded from the study 
to avoid potential effects of the appliances on healing of the lesions. Also, participants who chewed tobacco, 
smoked cigarettes or smoked Narghile (water pipe) were excluded from the study. Also, participants were 
excluded if they had received any treatment for their ulcers before inclusion in the study.
Medical assessment of each participant included detailed medical and dental histories, complaints, personal 
information (name, age, gender, occupation, education, marital status and address), full clinical examination, 
and selected laboratory tests (complete blood count, red blood cell folate, serum vitamin B12, and serum ferritin) 
were carried out for differential diagnosis and assisting exclusion of underlying medical disease following the 
methodology of previous literature16–19.
Ulcers were regarded as RAS when they were grey or yellowish in colour, surrounded by an erythematous 
margin, painful, recurrent and not associated with systemic disease16–19. All clinical examinations were carried 
out on a dental chair set with a light unit Daray angle poise extra-oral light source (Daray Lighting Ltd, Leighton 
Buzzard, and Bedfordshire, UK). Dental oral mirrors (15/16 inch, Hanhnenkratt GMBH, Germany), explorer 
probes (0700-9 anatomical handle single ended, ASA Dental Co, Italy) and periodontal probes were utilized 
during the intra-oral examinations.
Main study outcome measures were pain levels due to ulcers, size of ulcers and duration of ulcers. Ulcer size 
was recorded at study baseline using a digital caliber (Terensa, USA) which has an accuracy up to 0.01 mm. Also, 
pain assessment was carried out at study baseline using a VAS score recorded from 0 to 10; 0 meant no pain and 
10 meant the most severe pain. Then, the ulcers in the test group were exposed to 2350 ppm of ozone gas with 
a flow rate of 615 cc per minute for 60 seconds using the healOzone X4 machine (healOzone X4, Curozone, 
Germany) which required an adequate seal of its delivery system to be able to work and provide ozone8,14. An 
ozone measurement device was used to confirm the ppm of ozone delivered and a flow meter was used to confirm 
the flow rate immediately before the start of the study. Ozone was applied on the lesions through special dispos-
able silicone cups that permitted adequate seal and avoided gas escape which ensured the safety of the machine 
for human use8,14. No ozone could escape and therefore no ozone smell could be detected which allowed blinding. 
The large cup with an 8 mm diameter was used on each occasion and when the ulcer was larger than 8 mms then 
the cup application was repeated so that the entire area of the ulcer was treated with ozone. Ulcer size and pain 
assessment were then repeated as above daily for 15 days. Ulcers duration was determined by recording the time 
(in days) required for the ulcers to disappear.
Each participant was examined on a dental chair following the above described procedures everyday through-
out the study to also rule out any other changes in their oral and dental status apart from the assessed ulcers (such 
as having new orthodontic or prosthetic appliances, having dental pain due to other reasons, or having trauma 
to the mucosa or teeth). Subjects would have been excluded if they had any such changes to avoid any potential 
effects of such changes on ulcer healing as well as assessment of pain and ulcer size and duration. The participants 
were instructed not to use any systemic or local drugs for the treatment of the ulcers or their symptoms through-
out the period of the study. They were to be excluded from the study if they used any other therapy for the ulcers. 
In this study, all participants completed the study without any drop out (drop out rate was zero).
A control group of 69 RAS patients (39 women and 30 men, mean age  ±  SD: 27.4 ± 7.1 years) who matched 
the participants in the main study group with age and gender were also recruited into this study. The inclusion 
and exclusion criteria and medical assessment of the controls were the same as those followed during the recruit-
ment of participants in the test group. Pain assessment as well as recording ulcers size was carried out at study 
baseline following the same procedures as in the test group. The used healOzone machine was specially designed 
by having a switch at the back of the device which was switched to deliver only air and no ozone for the controls. 
Participants in the control group received the same treatment but with air only with no ozone and no participant 
was informed if they were in the test or the control group. The controls were also followed up every day for 15 
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days. Ulcer size and pain assessment were repeated daily for 15 days following the same procedures in the test 
group. Ulcer duration was determined by recording the time required for the ulcer to disappear.
One examiner blindly conducted all clinical examinations and intra-examiner reliability was evaluated on 
eight duplicate clinical examinations utilizing Kappa statistics. The Kappa value was 0.91 signifying a high agree-
ment. Also, inter-examiner reliability was evaluated by conducting the same eight examinations by another inves-
tigator; Kappa was 0.87 demonstrating high agreement. Neither the examiner nor the participants were aware of 
which participant received ozone or only air.
Statistical analysis. The data analysis was executed using the SPSS computer software (Statistical Package 
for the Social Sciences; version 19.0, SPSS Inc.). The Pearson Correlation test was utilized to test for correlation 
between participants’ demographic and pain levels, ulcer size and ulcer duration. A paired sample t-test was 
utilized to evaluate pain levels and ulcer size before and after ozone application in the main study group. The 
ANOVA test was used compare pain levels, ulcer size and ulcer duration between groups. Statistical significance 
levels were set at P  ≤  0.05 during all statistical analyses. The sample size for this study was estimated via the soft-
ware G* Power 3.1.9.2 (Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany) by utilizing data obtained 
following a pilot study. The repeated measurements design was used in the software, in which the ozone treatment 
was considered the independent factor and the ulcers size as the repeated measures factor. With a significant level 
of 5%, statistic power of 80%, and effect size of 20%, the minimum sample size was calculated as 52 participants 
for each group.
Results
RAS participants (69 participants and 69 controls) were included in the analysis. Ulcer duration in the test group 
ranged between 7 and 10 days (mean  ±  SD: 8.4 ± 0.8 days). On the other hand, ulcer duration in the control 
group ranged between 8 and 12 days (mean  ±  SD: 9.5 ± 0.6 days).
Table 1 presents the distribution of ulcer size among study groups at baseline and daily for 15 days. Ulcer size 
was reduced as time progressed in both groups; however, reduction in ulcer size was more pronounced in the test 
group where ozone was applied on RAS lesions.
Table 2 shows the distribution of VAS scores for pain levels among study groups at baseline and daily for 15 
days. VAS scores for pain in the test group were reduced after application of ozone, and were reduced with time 
more than those in the control group.
Correlations within the test group showed that no significant relationships were found between age and gen-
der on one side and each of ulcer duration, ulcer size, and pain levels (p > 0.05) (Table 3). On the other hand, 
within the control group; no significant relationships were found between age and each of ulcer duration, ulcer 
size and pain levels (p > 0.05) (Table 3). Also, no significant relationships were found between gender and each 
of ulcer size and pain levels among controls (p > 0.05). However, males had a lower ulcer duration than females 
(p = 0.020) (Table 3).
Furthermore, paired samples t-test showed that ulcer size was significantly reduced starting from the sec-
ond day following ozone application (p ≤ 0.002) and starting from the fourth day among controls (p ≤ 0.004) 
(Table 4). Also, paired samples t-test showed that pain levels were significantly reduced starting from the first 
day shortly following ozone application (p ≤ 0.001) and starting from the third day among controls (p ≤ 0.001) 
(Table 5).
Comparison between groups using the ANOVA test showed that there were no significant differences between 
groups regarding participants’ age, participants’ gender, ulcer size at study baseline, ulcer size at day 2, and pain 
levels at baseline (p > 0.05).
Recording time
Mean ulcer size in mm (SD)
Minimum ulcer size 
in mm
Maximum ulcer size 
in mm
Test group Control group
Test 
group
Control 
group
Test 
group
Control 
group
Study baseline 5.20 (1.25) 5.25 (1.26) 3.50 3.50 8.00 8.00
Day 1 5.20 (1.25) 5.25 (1.26) 3.50 3.50 8.00 8.00
Day 2 5.12 (1.18) 5.23 (1.23) 3.00 3.50 7.50 8.00
Day 3 4.67 (0.96) 5.21 (1.21) 3.00 3.50 6.50 8.00
Day 4 3.93 (0.87) 5.16 (1.18) 2.50 3.50 5.50 8.00
Day 5 3.10 (0.84) 4.52 (1.14) 2.00 3.00 4.50 7.00
Day 6 1.82 (0.73) 3.91 (1.04) 1.00 2.50 3.00 6.00
Day 7 0.78 (0.47) 2.86 (1.07) 0.00 1.00 1.50 5.00
Day 8 0.27 (0.32) 1.65 (0.94) 0.00 0.00 1.00 3.50
Day 9 0.03 (0.12) 0.52 (0.55) 0.00 0.00 0.50 1.50
Day 10 0.00 (0.00) 0.31 (0.12) 0.00 0.00 0.00 0.50
Day 11 0.00 (0.00) 0.10 (0.11) 0.00 0.00 0.00 0.50
Day 12 0.00 (0.00) 0.04 (0.14) 0.00 0.00 0.00 0.20
Days 12 to15 0.00 (0.00) 0.00 (0.00) 0.00 0.00 0.00 0.00
Table 1.  Distribution of means, standard deviations, minimum and maximum values of recorded ulcer 
size among study groups (n = 69 for each group). SD: Standard Deviation.
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On the other hand, ulcer duration, ulcer size from day 3 untill day 10, and pain levels from day 1 untill day 10 
were more reduced in the test group treated with ozone in comparison to controls (p ≤ 0.012).
Discussion
The findings of this study demonstrated that application of ozone for 60 seconds on RAS lesions resulted in lower 
pain levels and improved healing of ulcers. Therefore, the null hypothesis of the study was rejected.
The healOzone X4 machine was utilized to produce and deliver ozone in this study because it was employed 
in many clinical trials previously and documented to be safe owing to the total confinement of ozone within 
the machines delivery system8,12,13,15. Miller and Hodson8 established that the Ozicure machine caused ozone 
accumulation to unsafe levels for humans typically if operated without adequate suction; and thus should not be 
used. Alternatively, the healOzone machine was confirmed safe to use since it is designed to function only if the 
delivering cups provide an adequate seal to avoid ozone leakage8,12,13,15.
In this study, ozone was directly applied to oral mucosa and did not cause any negative tissue reaction. This 
harmonizes with the findings of previous studies which concluded that ozone had less toxic effects on human oral 
epithelium and gingival fibroblast cells than chlorhexidine, sodium hypochlorite or hydrogen peroxide26. Also, 
Hauser-Gerspach et al.27 found that ozone did not affect osteoblastic cell adhesion and proliferation. In addition, 
previous studies applied ozone directly on teeth, soft periodontal tissues, gingiva, oral mucosa, bone and periim-
plant tissues and no adverse events were recorded in any study3–6,12,13,26–32.
The findings of this study demonstrated that pain levels were significantly reduced following ozone application 
on RAS ulcers. This concurs with the findings of previous studies that applied ozone to soft tissues and bone dur-
ing third molar extraction and revealed that ozone application was associated with reduction in pain levels28,30,31. 
Also, this supports the hypothesis that ozone is associated with analgesic effects1–5.
The results of this study showed that ulcers healing duration as well as ulcers size were significantly reduced 
following the application of ozone. This might be explained by ozone properties including being a powerful 
Recording time
Mean VAS score for pain (SD)
Minimum VAS score 
for pain
Maximum VAS score 
of pain
Test group Control group
Test 
group
Control 
group
Test 
group
Control 
group
Study baseline 7.68 (0.81) 7.58 (0.83) 6 6 10 10
Day 1 5.61 (0.97) 7.58 (0.83) 3 6 8 10
Day 2 4.30 (1.06) 7.58 (0.83) 2 6 6 10
Day 3 3.19 (1.20) 6.90 (0.82) 1 5 5 9
Day 4 2.68 (1.05) 6.36 (0.62) 1 5 5 8
Day 5 2.10 (0.86) 5.29 (0.62) 1 4 4 6
Day 6 1.59 (0.60) 4.14 (0.60) 1 3 3 5
Day 7 1.03 (0.54) 2.83 (0.64) 0 1 2 4
Day 8 0.48 (0.53) 1.57 (0.76) 0 0 2 3
Day 9 0.03 (0.17) 0.67 (0.07) 0 0 1 2
Day 10 0.00 (0.00) 0.09 (0.28) 0 0 0 1
Day 11 0.00 (0.00) 0.03 (0.17) 0 0 0 1
Days 12 to 15 0.00 (0.00) 0.00 (0.00) 0 0 0 0
Table 2.  Distribution of means, standard deviations, minimum and maximum VAS score values of 
reported pain levels among study groups (n =  69 for each group). SD: Standard Deviation.
Age Gender
Test group
Control 
group Test group
Control 
group
Pain levels
 R= 0.176 0.167 0.02 0.156
 P= 0.149 0.170 0.867 0.201
Ulcer size
 R= 0.116 0.178 0.003 0.196
 P= 0.341 0.143 0.980 0.107
Ulcer duration
 R= 0.126 0.199 0.043 0.279* 
 P= 0.303 0.101 0.728 0.020
Table 3.  Correlations between age and gender on one side and each of pain levels, ulcer size and ulcer 
duration among the study participants (n =  69 for each group). R =  Pearson’s correlation coefficient;  
P =  Probability levels; *Significant relation.
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oxidant and ability to stimulate blood circulation and immune responses1–5. An inflammatory cell infiltrate 
(including neutrophils and lymphocytes) exists beneath ulcers and produces inflammatory mediators that are 
responsible for the inflammatory process seen in RAS lesions. Being a powerful oxidant; ozone affects both the 
cellular and humoral immune system, oxidizes toxins making their excretion easier, encourages production of 
immunocompetent cells and immunoglobulins, improves phagocytosis function of macrophages, and induces 
production of tumor necrotizing factor (TNF-α ), leukotrienes, interleukins, and prostaglandins that ends inflam-
mation and accelerate tissue healing33. Furthermore, ozone enhances the oxygen carrying capacity of blood lead-
ing to more efficient cellular metabolism of inflamed tissues and better utilization of energy via activation of 
Group (n =  69 
for each group) Ulcer size pairs
Paired Differences
T df
Sig. 
(2-tailed)
Std. Error 
Mean
95% Confidence 
Interval of the 
Difference
Lower Upper
Test
baseline – Day 2 0.02448 0.03086 0.12856 3.256 68 0.002
baseline – Day 3 0.05920 0.41086 0.64711 8.936 68 0.000
baseline – Day 4 0.07045 1.12753 1.40870 17.999 68 0.000
baseline – Day 5 0.07948 1.93561 2.25280 26.350 68 0.000
baseline – Day 6 0.09023 3.19675 3.55687 37.423 68 0.000
baseline – Day 7 0.10923 4.19508 4.63100 40.402 68 0.000
baseline – Day 8 0.12183 4.68443 5.17064 40.447 68 0.000
baseline – Day 9 0.14623 4.87486 5.45847 35.332 68 0.000
baseline – Day 10 0.15144 4.89346 5.49785 34.308 68 0.000
Control
baseline – Day 2 0.01449 − 0.01443 0.04341 1.000 68 0.321
baseline – Day 3 0.01881 − 0.00130 0.07376 1.927 68 0.058
baseline – Day 4 0.02912 0.02885 0.14506 2.986 68 0.004
baseline – Day 5 0.04198 0.64087 0.80840 17.262 68 0.000
baseline – Day 6 0.04896 1.24288 1.43827 27.382 68 0.000
baseline – Day 7 0.06032 2.26369 2.50443 39.523 68 0.000
baseline – Day 8 0.07022 3.45407 3.73433 51.183 68 0.000
baseline – Day 9 0.09930 4.52648 4.92279 47.578 68 0.000
baseline – Day 10 0.14537 4.91281 5.49299 35.790 68 0.000
Table 4.  Paired samples t-test to compare differences in ulcer size within each study group.
Group (n =  69 
for each group) Pain level pairs
Paired Differences
T df
Sig. 
(2-tailed)
Std. Error 
Mean
95% Confidence 
Interval of the 
Difference
Lower Upper
Test
baseline – Day 1 0.10389 1.86516 2.27977 19.949 68 0.000
baseline – Day 2 0.10136 3.17456 3.57907 33.316 68 0.000
baseline – Day 3 0.12148 4.25034 4.73517 36.982 68 0.000
baseline – Day 4 0.10728 4.78593 5.21407 46.607 68 0.000
baseline – Day 5 0.09326 5.39361 5.76582 59.827 68 0.000
baseline – Day 6 0.08696 5.91344 6.26048 70.000 68 0.000
baseline – Day 7 0.08717 6.47823 6.82612 76.313 68 0.000
baseline – Day 8 0.07608 7.05108 7.35472 94.673 68 0.000
baseline – Day 9 0.09422 7.46416 7.84019 81.217 68 0.000
baseline – Day 10 0.09792 7.48577 7.87655 78.446 68 0.000
Control
baseline – Day 3 0.05651 0.56839 0.79393 12.053 68 0.000
baseline – Day 4 0.07407 1.06960 1.36519 16.437 68 0.000
baseline – Day 5 0.09023 2.10980 2.46991 25.377 68 0.000
baseline – Day 6 0.08875 3.25769 3.61188 38.702 68 0.000
baseline – Day 7 0.07836 4.59725 4.90999 60.662 68 0.000
baseline – Day 8 0.08385 5.84718 6.18180 71.733 68 0.000
baseline – Day 9 0.08191 6.74960 7.07649 84.400 68 0.000
baseline – Day 10 0.08910 7.31496 7.67054 84.097 68 0.000
Table 5.  Paired samples t-test to compare differences in pain levels within each study group.
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aerobic pathways of metabolism (Krebs cycle, glycolysis, and β -oxidation of fatty acids). In addition, oxidant 
activity of ozone initiates protein synthesis and enhances cellular ribosomes and mitochondria. Consequently, 
cellular activity and regeneration potentials will be improved and boost tissue healing33.
Such properties might potentially accelerate healing of the lesions leading to reductions of ulcer size and ulcer 
duration. This agreed with previous studies that applied ozone for the treatment of other types of ulcers (such 
as ulcers involving the stomach, duodenum, veins, and skin) and revealed that ozone was associated with better 
healing of the ulcers20–25. However, this contrasts with the findings of previous studies that applied ozone to bone 
and soft tissues during third molar surgery and found that it did not affect healing time but significantly reduced 
pain levels28,30,31. This contrast could be attributable to differences in sample size and study design such as the 
utilization of another machine that generated dramatically lower ozone concentrations and lower flow rates with a 
much lower delivered dose of ozone, application of ozone for shorter time periods and applying ozone to different 
tissues during bone surgery.
This study demonstrated that ozone application improved healing of ulcers and reduced pain.
Therefore, ozone should be considered for the management of RAS lesions as it can reduce treatment time, 
reduce oral ulcers and impacts on quality of life by reducing pain and ulcer duration, and thus improve patients’ 
perception of and compliance with treatment. Also, application of ozone is convenient, fast and monitored since 
it is administered by this special machine that can control concentration, volume, application site and timing of 
ozone application.
The study limitations are that the size of the study sample is small; nevertheless, the sample size in this study 
is comparable to or even larger than the sample size in previous investigations in this field15,18–25. Also, pain 
assessment in this study depended on subjective reporting of patients’ opinions regarding pain levels. This is an 
inherent drawback in subjective and self reporting of symptoms. However, all attempts were made to provide 
patients with a full explanation of the VAS scale used to score pain levels in this study. Another limitation of using 
ozone as a therapy for RAS patients is that there is no home device for patients to use, and that some patients 
would have very frequent RAS attacks and would not be able to attend the clinic each time they have an attack. 
Current studies are in progress to investigate the effects of ozone therapy on frequency of RAS attacks as well as 
to test new methods for ozone administration schedules and dosage that can be applied by patients at home. It 
would be useful to establish whether changes in ozone dosage or schedule of administration might achieve more 
impressive answers for patients in future.
Further investigations are also required on larger samples, on different types of oral ulcers, and on different 
populations, as well as to identify the potential effects of ozone on different types (major, minor and herpetiform 
ulcers), frequency and number of RAS lesions. Also, studies are required to measure effects of ozone therapy 
against or in conjunction with other treatment paradigms used for management of RAS.
Conclusions
Application of ozone on RAS lesions for 60 seconds lead to a reduction of pain levels as well as enhanced healing 
of the ulcers by reducing the size and duration of ulcers.
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